Skip to main content

Zinc Disease Interactions

There are 2 disease interactions with Zinc (zinc sulfate).

Moderate

Chromium/selenium/zinc (applies to Zinc) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

The trace metals, chromium and zinc, are excreted primarily in the urine. Selenium is partially excreted in the urine. Supplemental doses of these agents may need to be adjusted, reduced, or omitted in patients with renal dysfunction.

References (3)
  1. (2001) "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA
  2. (2022) "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc
  3. "Product Information. Sele-Pak (selenium)." Fujisawa
Moderate

Trace metals (applies to Zinc) malabsorption syndromes

Moderate Potential Hazard, Moderate plausibility.

The trace metals manganese, chromium, copper, selenium, and zinc are absorbed in the GI tract from dietary sources and following administration of oral supplements. GI absorption may be decreased in patients with malabsorption syndromes. Therefore, larger dosages may be required when these supplements are given orally. Parenteral administration may be appropriate.

References (6)
  1. (2001) "Product Information. Galzin (zinc acetate)." Teva Pharmaceuticals USA
  2. (2022) "Product Information. Chroma-Pak (chromic chloride hexahydrate)." Apothecon Inc
  3. "Product Information. Sele-Pak (selenium)." Fujisawa
  4. (2001) "Product Information. Copper Sulfate (copper sulfate)." Humco Holding Group
  5. (2001) "Product Information. Manganese Chloride (manganese chloride)." Abbott Pharmaceutical
  6. (2001) "Product Information. Manganese Sulfate (manganese sulfate)." American Regent Laboratories Inc

Switch to consumer interaction data

Zinc drug interactions

There are 150 drug interactions with Zinc (zinc sulfate).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer